Atevirdine
From Wikipedia, the free encyclopedia
| Atevirdine | |
|---|---|
|
[4-[3-(ethylamino)pyridin-2-yl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone |
|
| Identifiers | |
| CAS number | 136816-75-6 |
| PubChem | 60848 |
| ChemSpider | 54835 |
| ChEMBL | CHEMBL280527 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C21H25N5O2 |
| Molar mass | 379.46 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Ateviridine is non-nucleoside reverse transcriptase inhibitor that has been studied for the treatment of HIV.[1]
References [edit]
- ^ Morse GD, Reichman RC, Fischl MA, et al. (January 2000). "Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams". Antiviral Res. 45 (1): 47–58. doi:10.1016/S0166-3542(99)00073-X. PMID 10774589.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |